Peripheral Cannabinoid-1 Receptor Blockade Ameliorates Cystitis Severity-Reference-Cited by-同舟云学术

Peripheral Cannabinoid-1 Receptor Blockade Ameliorates Cystitis Severity

Published:2022-05-31 Issue: Volume: Page:
ISSN:2578-5125
Container-title:Cannabis and Cannabinoid Research
language:en
Short-container-title:Cannabis and Cannabinoid Research

Author:

Hinden Liad¹^ORCID,Ludyansky Rami²,Leidershnaider Sary³,Harris Yoav³,Nemirovski Alina¹,Gofrit Ofer N.²,Tam Joseph¹,Hidas Guy²

Affiliation:

1. Obesity and Metabolism Laboratory, Department of Drug Research, School of Pharmacy, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel.

2. Department of Urology Hadassah Medical Center, Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.

3. In partial fulfillment of MD requirements, Hadassah Hebrew University Medical Center, Jerusalem, Israel.

Publisher

Mary Ann Liebert Inc

Subject

Pharmacology (medical),Complementary and alternative medicine,Pharmacology

Link

https://www.liebertpub.com/doi/pdf/10.1089/can.2022.0077

Reference34 articles.

1. The standardisation of terminology in lower urinary tract function: report from the standardisation sub-committee of the International Continence Society

2. Worldwide prevalence estimates of lower urinary tract symptoms, overactive bladder, urinary incontinence and bladder outlet obstruction

3. Hemorrhagic Cystitis Due to Cyclophosphamide

4. Cyclophosphamide cystitis—Identification of acrolein as the causative agent

5. Functional and Immunohistochemical Characterization of CB1 and CB2 Receptors in Rat Bladder

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Complex Regional Pain Syndrome Type I: Evidence for the CB1 and CB2 Receptors Immunocontent and Beneficial Effect of Local Administration of Cannabidiol in Mice;Cannabis and Cannabinoid Research;2023-10-30

2. 4,5-Dihydro-1H-pyrazole/3,4-Diarylpyrazoline class of cannabinoid-1 (CB1R) receptor antagonists and their potential in medicinal applications;Cannabis Use, Neurobiology, Psychology, and Treatment;2023